Community Academic Profiles–

Paul Yock, MD

Back to Profile

Publication Details

  • Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

    Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ. JACC Cardiovasc Interv. 2009; 2 (8): 779-84

    The aim of this study was to compare the vessel response between zotarolimus-eluting stents (ZES) and paclitaxel-eluting stents (PES) using intravascular ultrasound.

    PubMedID: 19695548

Stanford Medicine Resources:

Footer Links: